FDA extends comment period for NDI draft guidance

September 19, 2011

The U.S. Food and Drug Administration (FDA) is extending the comment period for the New Dietary Ingredient (NDI) draft guidance notice by 60 days. The announcement, published in the Sept. 7 Federal Register notice, will extend the comment period from Oct. 3 to Dec. 2, 2011. The FDA first announced the availability of a draft guidance for industry on July 5, and requested comments. The agency is extending the comment period in response to a request for more time to allow interested persons additional time to submit comments.

Federal Register notice (pdf)

Story Tools